KBI Biopharma

1 min read

Characterization & Control Strategy for an ADC

1 min read

Breaking Barriers: Combining Cell Line Development Innovation with Improved Process Development Workflows to Streamline Path to FIH

9 min read

Rapid Timeline to Tox Starting with KBI Biopharma's SUREtechnology Platform™, Powered by Selexis®

1 min read

Driving CDMO Efficiency - The Power of Flexible Platforms and Digital Data Access

3 min read

Adeno-Associated Virus-Mediated Gene Therapy: Analytical Advancements in Characterizing Size Distribution using SV-AUC and Multi-Wavelength Analysis for Accurate Identification of Resolved Species

Poster: Comprehensive Size Distribution Analysis of Adeno-Associated Virus Fill States

1 min read

Poster: Characterization and Quantification of Adeno-associated Virus Fill States Using Analytical Ultracentrifugation

1 min read

Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics

2 min read

Harnessing Digital Innovation in Analytics and Formulation Sciences: KBI Biopharma's Journey to Becoming a Next-Generation CDMO

1 min read

Revolutionizing Particle Characterization in Biologics: A Focus on Image Analysis and Machine Learning